Abstract The aim of this study was to examine the occurrence of end-stage renal disease (ESRD) in Slovak children, to compare it with earlier Slovak data and with data from other European countries, and to explore etiology. Over the years
Introduction
The pediatric population suffering from end-stage renal disease (ESRD) in Europe is growing. Children with formerly lethal diseases nowadays survive until adulthood and beyond [11] . The reported number of children on renal replacement therapy (RRT) has almost tripled during a relatively short period of 15 years [8, 13, 14] .
Nevertheless, reliable epidemiological information on ESRD and RRT in European children is not easy to obtain. One source of information is the annual reports of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA), but these reports are somewhat limited since data are often lacking, especially from Central and Eastern European countries. This is probably a consequence of the absence of official national or regional registries in most of these countries, including Slovakia [15] . In 2007, the European Society of Paediatric Nephrology (ESPN) began collecting data on pediatric renal replacement therapy (RRT) patients exclusively on the basis of national or large regional registries in an attempt to solve the problem of insufficient information.
In Slovakia, only two pediatric epidemiologic studies on this topic have been published so far. The first such study was by Zvara et al. in the years 1975 Zvara et al. in the years -1977 and included children under the age of 15 years with chronic kidney disease (CKD) [17] . As a result of unavailability of dialysis and transplantation, the prevalence of RRT at that time was only 1.5 per million age-related population (pmarp) under 15 years of age (0.4 per million total population-pmtp). The next study on Slovak children was done in the year 2002 by Podracka et al., but this study was done on CKD children in a different age category (under 18 years of age) revealing a prevalence rate of 29.3 pmarp for this age group (7.4 children pmtp) [10] .
Up to now, a national register with the potential of monitoring health care of pediatric end-stage renal disease patients has not been established in Slovakia. Therefore, the main aims of the present study are:
1. To evaluate the actual incidence and prevalence rates of ESRD and RRT in Slovak children; 2. To compare the results regarding 2003-2009 with those from earlier epidemiological surveys carried out in Slovakia; 3. To compare the incidence and prevalence rates of ESRD and RRT in Slovak children with those of children from other European countries; 4. To compare the etiology, i.e., primary renal diseases and treatment modes, with earlier studies on Slovak children and on children from other European countries.
Materials and methods

Patients
According to a new ERA-EDTA policy, this epidemiologic study evaluated data from all four tertiary centers for Incidence and prevalence rates were calculated as pmarp and pmtp in the different age categories (0-4, 5-9, 10-14, 15-18). Prevalence rates were expressed as the number of ESRD patients alive and on RRT on 31st December of each year. Data on RRT from other European countries were derived from ESPN/ERA-EDTA annual reports [5, 6] .
Statistical analyses
Descriptive data regarding incidence and prevalence rates of RRT from 2003 to 2009 were presented. Poisson regression was used to find significant differences between the last study from 2002 and actual data from 2009. Differences between Slovakia and neighboring countries were compared over the years 2007-2008 using test of proportions. The differences were considered statistically significant at a p level of 0.05. SAS 9.2 was used for the statistical analyses.
Results
Between 1 January 2003 and 31 December 2009, 52 new patients reached ESRD before the age of 19 years and initiated RRT in Slovakia. The median age of the patients at the start of RRT was 12 years, and the range was 0-18 years. The male/female ratio of the patients was 1.58.
Age distribution and incidence and prevalence rates
The largest portion of the patients (n=20) was aged 10 to 14 years when they initiated RRT; 18 patients were 15 to 18 years old; and six were younger than age of 5 years at the time of RRT initiation ( Table 1 ). The median annual incidence rate of RRT (during the study period 2003-2009) was 6.6 pmarp under age 15 years (1.5 pmtp). The current prevalence rate of RRT in Slovak children under 15 years old (measured on 31 December 2009) was found to be 24.1 pmarp (3.7 pmtp). Table 1 shows the incidence and prevalence rates in detail during the whole study period. The average mortality of patients under the age of 15 years on RRT during the whole period was 1.3%.
Comparison with earlier Slovak epidemiological surveys
In the first Slovak study, done in 1977 by Zvara et al., only the prevalence rate under the age of 15 years was explicitly described (1.5 pmarp, 0.4 pmtp) [17] . The study performed in 2002 presented data regarding children under the age of 18 years [10] . To allow for a direct comparison, we recalculated the rates for children under the age of 15 years. The incidence rate was then 4.1 pmarp under 15 years (0.7 pmtp), and the prevalence rate was 18.6 pmarp under 15 years (3.2 pmtp). A slightly positive trend both for incidence and prevalence is currently present, although the differences between 2002 and 2009 are not statistically significant.
Slovakia compared to other European countries
The comparison of incidence and prevalence of RRT among Slovak children with children from other European countries using data published by ESPN in 2009-2010 for the years 2007-2008 is presented in Table 2 . The comparison with Slovakia's neighboring countries and with the European average shows no significant difference in incidence. The Slovak prevalence does not differ than that of most of its neighbors, but it is significantly lower compared with neighboring Austria. The same holds true in the comparison of Slovak prevalence with some other 
Treatment mode
During the study period, 27 patients (51.9%) (younger than 19 years old) started RRT on PD and 24 patients (46.2%) started their RRT on HD. Only one patient (1.9%) was transplanted preemptively. Out of all the first transplantations, 22.0% were from living-related donors. In previous Slovak surveys, initial treatment modalities were not described [10, 17] . Compared to published data on the overall proportion of preemptive transplantations in Europe (15.1%), the proportion of preemptive transplantations in Slovak children is significantly lower. Regarding the prevalent treatment modalities measured on 31 December 2008, the proportion of HD patients (n=8; 20.5%) does not significantly differ from the ERA-EDTA data (n=180; 13.1%), and the proportion of PD patients (n=12; 30.8% vs n=100; 7.3%) is significantly higher and of transplanted patients (n=19; 48.7% vs n=1097; 79.7%) significantly lower compared to the ERA-EDTA 2010 annual report.
Discussion
This study presents an overview of the epidemiology and etiology of ESRD and RRT in Slovak children, focusing on changes observed in the period 2003-2009 compared to historical data and data on the European perspective. The median annual incidence rate of RRT in Slovak children under age 15 years in this period was 6.6 pmarp. These rates were somewhat higher than that in the preceding study on Slovak children in 2002 [17] , but without statistical significance. Data on the incidence of RRT regarding the first Slovak study from 1978 are not available, but it seems likely that the number of patients initiating RRT was lower as a consequence of the unavailability of dialysis and transplantation in the past. Compared with neighboring countries and with the European average, no significant differences in incidence rates were found. Explanations for these similarities are the similar demographic structure but also the seemingly comparable availability of dialysis. An increase in the incidence rates of RRT can thus be expected, as the European RRT incidence is currently rising [6, 13, 15] .
On the basis of the available prevalence data (1. The predominance of congenital and hereditary reasons as the main causes of ESRD in children has similarly been found in a study on neighboring Poland [16] and in many other previous studies on Europe [1, 3, 7] and other parts of the world [9, 12] . A study of the British Association of Paediatric Nephrology published in December 2009, the most recent European study, reported a higher proportion of CAKUT (50.0%) and congenital nephrosis (9.3%) [7] . A Dutch study on the period 1987-2001 reported a relatively very high proportion of urethral valves (14.3%) as the reason for ESRD, which contrasts with the Slovak results, in which there was zero contribution of urethral valves among RRT patients. Environmental, ethnic, and other differences might explain the different occurrence of primary renal diseases in Europe compared to our findings [15] .
Strengths and limitations
An important strength of our study is that we obtained data on the entire country using a rigorous data collection. A limitation is the relatively small number of children, which limits the potential for subgroup analyses.
Conclusion
A slightly positive trend both for incidence and prevalence rates of pediatric RRT patients has been present in Slovakia during the past decade, although no significant difference compared to the last study (2002) was found. The comparison with the neighboring countries and with the European average shows no significant differences in incidence. The prevalence does not significantly differ from that of most of its neighbors but is significantly lower compared with neighboring Austria and some other (mostly western) European countries as well as the European average.
A central national registry for children on RRT should be established, not only to facilitate epidemiological analyses and longitudinal studies but also as a first step toward monitoring and improving the quality of health care and quality of life of Slovak children.
